| dbo:abstract | - S-17092 is a drug which acts as a selective inhibitor of the enzyme prolyl endopeptidase. This enzyme is involved in the metabolic breakdown of a number of neuropeptide neurotransmitters in the brain, and so inhibiting the action of the enzyme increases the activity of these neuropeptides. This produces nootropic effects which make S-17092 a promising and novel treatment for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. (en)
|
| dbo:fdaUniiCode | |
| dbo:pubchem | |
| dbo:thumbnail | |
| dbo:wikiPageID | |
| dbo:wikiPageLength | - 4415 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID | |
| dbo:wikiPageWikiLink | |
| dbp:c | |
| dbp:chemspiderid | |
| dbp:f | |
| dbp:h | |
| dbp:iupacName | - [-1-2-octahydro-1H-indole (en)
|
| dbp:legalUs | - Investigational New Drug (en)
|
| dbp:n | |
| dbp:o | |
| dbp:pubchem | |
| dbp:smiles | - O=C[C@H]4N[C@H]5CCCC[C@H]5C4 (en)
|
| dbp:stdinchi | |
| dbp:stdinchikey | - JNUXCIMICQKTPX-RQUKQETFSA-N (en)
|
| dbp:unii | |
| dbp:verifiedfields | |
| dbp:verifiedrevid | |
| dbp:watchedfields | |
| dbp:width | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| gold:hypernym | |
| rdf:type | |
| rdfs:comment | - S-17092 is a drug which acts as a selective inhibitor of the enzyme prolyl endopeptidase. This enzyme is involved in the metabolic breakdown of a number of neuropeptide neurotransmitters in the brain, and so inhibiting the action of the enzyme increases the activity of these neuropeptides. This produces nootropic effects which make S-17092 a promising and novel treatment for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. (en)
|
| rdfs:label | |
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| isdbo:wikiPageWikiLink of | |
| isfoaf:primaryTopic of | |
